Baybio Stem Cell Show and Tell
How does a stem cell investigator find grant dollars?
Why does one venture capitalist decide to invest in a stem cell company and another does not?
How does an executive of an emerging stem cell company navigate the commercialization issues?
These questions and more will be addressed Sept. 19 during a panel discussion at UC San Francisco sponsored by Baybio
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.